Flavahan Nicholas A, Flavahan Sheila, Mitra Srabani, Chotani Maqsood A
Heart and Lung Research Institute, Ohio State University, 473 West 12th Avenue, Columbus OH 43210, USA.
Rheum Dis Clin North Am. 2003 May;29(2):275-91, vi. doi: 10.1016/s0889-857x(03)00021-8.
The scleroderma (SSc) disease process involves dramatic dysfunction in acute and chronic vascular regulatory mechanisms; it presents initially with heightened vasoconstrictor or vasospastic activity and progresses to structural derangement or vasculopathy of the microcirculation. This article discusses the regulatory mechanisms that contribute to this dysfunction and the vascular changes in the context of the other aspects of the SSc disease process in a novel attempt to integrate the individual pathologies of the disease process.
硬皮病(SSc)的疾病进程涉及急性和慢性血管调节机制的显著功能障碍;最初表现为血管收缩或血管痉挛活动增强,随后发展为微循环的结构紊乱或血管病变。本文讨论了导致这种功能障碍的调节机制以及在硬皮病疾病进程其他方面背景下的血管变化,这是一种整合疾病进程中各个病理情况的新尝试。